Evidence map›Paper›PMID 37648727›Full record

ArticleScientific reports2023

Egyptian mandarin peel oil's anti-scabies potential via downregulation-of-inflammatory/immune-cross-talk: GC-MS and PPI network studies.

Abeer H Elmaidomy, Nehad M Reda Abdel-Maqsoud, Omar Y Tammam, Islam M Abdel-Rahman, Mahmoud A Elrehany, Hussain T Bakhsh, Faisal H Altemani, Naseh A Algehainy, Mubarak A Alzubaidi, Faisal Alsenani and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Phytomedicines and conventional drugs in scabies management.GMS hygiene and infection control · 2026
    Review
  3. Sustainable MnOPharmaceuticals (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Abeer H ElmaidomyDepartment of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. Abeer011150@pharm.bsu.edu.eg.
Nehad M Reda Abdel-MaqsoudDepartment of Pathology, Faculty of Pharmacy, Deraya University, Minya, Egypt.
Omar Y TammamDepartment of Biochemistry, Faculty of Pharmacy, New Valley University, Kharga, New Valley, Egypt.
Islam M Abdel-RahmanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, Minya, Egypt.
Mahmoud A ElrehanyDepartment of Biochemistry, Faculty of Pharmacy, Deraya University, New Minya, Egypt.
Hussain T BakhshDepartment of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Faisal H AltemaniDepartment of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia.
Naseh A AlgehainyDepartment of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia.
Mubarak A AlzubaidiDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Faisal AlsenaniDepartment of Pharmacognosy, College of Pharmacy, Umm Al-Qura University, Mecca, Saudi Arabia.
Ahmed M SayedDepartment of Pharmacognosy, Faculty of Pharmacy, Nahda University, Beni-Suef, 62513, Egypt.
Usama Ramadan AbdelmohsenDepartment of Pharmacognosy, Faculty of Pharmacy, Deraya University, Minya, Egypt. usama.ramadan@mu.edu.eg.
Eman Maher ZahranDepartment of Pharmacognosy, Faculty of Pharmacy, Deraya University, Minya, Egypt.
Minia University · EGDeraya UniversityKing Abdulaziz University · SAUniversity of Tabuk · SABeni-Suef University · EGNahda University · EGSouth Valley University · EGUmm al-Qura University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study investigated the scabicidal potential of Egyptian mandarin peel oil (Citrus reticulata Blanco, F. Rutaceae) against sarcoptic mange-in-rabbits. Analysis of the oil's GC-MS identified a total of 20 compounds, accounting for 98.91% of all compounds found. Mandarin peel oil topical application improved all signs of infection, causing a scabicidal effect three days later, whereas in vitro application caused complete mite mortality one day later. In comparison to ivermectin, histopathological analysis showed that the epidermis' inflammatory-infiltration/hyperkeratosis-had disappeared. In addition to TIMP-1, the results of the mRNA gene expression analysis showed upregulation of I-CAM-1-and-KGF and downregulation of ILs-1, 6, 10, VEGF, MMP-9, and MCP-1. The scabies network was constructed and subjected to a comprehensive bioinformatic evaluation. TNF-, IL-1B, and IL-6, the top three hub protein-coding genes, have been identified as key therapeutic targets for scabies. From molecular docking data, compounds 15 and 16 acquired sufficient affinity towards the three screened proteins, particularly both possessing higher affinity towards the IL-6 receptor. Interestingly, it achieved a higher binding energy score than the ligand of the docked protein rather than displaying proper binding interactions like those of the ligand. Meanwhile, geraniol (15) showed the highest affinity towards the GST protein, suggesting its contribution to the acaricidal effect of the extract. The subsequent, MD simulations revealed that geraniol can achieve stable binding inside the binding site of both GST and IL-6. Our findings collectively revealed the scabicidal ability of mandarin peel extract for the first time, paving the way for an efficient, economical, and environmentally friendly herbal alternative for treating rabbits with Sarcoptes mange.

Indexed as

LagomorphaScabiesAcyclic MonoterpenesAnimalsDown-RegulationEgyptGas Chromatography-Mass SpectrometryInterleukin-6LigandsMolecular Docking SimulationPlant ExtractsRabbitsAcyclic MonoterpenesgeraniolInterleukin-6LigandsPlant Extracts

Identifiers

PMID37648727
PMCPMC10469216
OpenAlexW4386289664

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.